WASHINGTON -- U.S. imports of Chinese-made pharmaceuticals are soaring to meet shortages at home, with authorities in some cases greenlighting drugs not formally approved for American use.
Treatments for cancer, cardiovascular diseases drive rising imports
The U.S. has been importing more chemotherapy treatments, immunosuppressants and other lifesaving drugs from China. © Reuters
WASHINGTON -- U.S. imports of Chinese-made pharmaceuticals are soaring to meet shortages at home, with authorities in some cases greenlighting drugs not formally approved for American use.